首页> 外文学位 >Utilization and mechanism of fluence and fluence rate effects in photodynamic therapy.
【24h】

Utilization and mechanism of fluence and fluence rate effects in photodynamic therapy.

机译:通量和通量率效应在光动力治疗中的利用及其机理。

获取原文
获取原文并翻译 | 示例

摘要

Using the photosensitizer HPPH (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a), it has been determined that the in vivo biological responses, such as vascular permeability and tumor response, to Photodynamic Therapy (PDT) are highly dependent on fluence rate (the power per unit area of the irradiating light source). The increased vascular permeability is maximized by using a low fluence, 48 J/cm2, delivered at a low fluence rate, 28 mW/cm2. It was hypothesized that this novel use of PDT would facilitate the delivery of Doxil® to tumors and thus enhance its therapeutic index. PDT (48 J/cm2, 14 mW/cm 2) followed immediately by the systemic administration of Doxil ® results in a 2–3 fold increase in the uptake of the macromolecular chemotherapeutic agent in Colon-26 tumors 3 hours after injection compared to untreated controls. One injection of a low dose of Doxil® (5 mg/kg) immediately after PDT optimized for macromolecular delivery results in cures for 80% of treated mice, while treatment with the same dose of either Doxil® or PDT alone resulted in 0% or 18% cures, respectively.; As the true photodynamic dose is the quantity of singlet oxygen generated during treatment, it can be hypothesized that the mechanism underlying the observed fluence rate effects is an enhanced deposition of this reactive oxygen species at low fluence rates. It has been shown in the literature that in vivo photosensitizer photobleaching can be used as an indirect measure of singlet oxygen deposition. Unlike other photosensitizers studied (e.g. PPIX or mTHPC) it has been found that in vivo HPPH photobleaching is more efficient at high fluence rates than low fluence rates. This result suggests that an anoxic pathway, possibly due to Type I photochemistry, is responsible for in vivo HPPH photobleaching. It was further found that HPPH photobleaching in vivo can be described as a function of fluence and fluence rate. Using this mathematical description of photobleaching, an expression for photodynamic dose which accurately predicts tumor response at given fluence and fluence rates is derived.
机译:使用光敏剂HPPH(2- [1-己氧基氧基乙基] -2-癸基焦脱镁叶绿酸-a),已确定对光动力疗法的 in vivo 生物学反应,例如血管通透性和肿瘤反应(PDT)高度依赖于注量率(辐射光源每单位面积的功率)。通过使用低注量48 J / cm 2 可以最大程度地增加血管通透性,而低注量率28 mW / cm 2 可以使血管通透性增加。据推测,PDT的这种新颖用途将促进Doxil ®向肿瘤的递送,从而提高其治疗指数。 PDT(48 J / cm 2 ,14 mW / cm 2 )然后立即全身性施用Doxil ®导致2–3与未处理的对照组相比,注射后3小时在结肠26肿瘤中大分子化疗药物的吸收增加了3倍。在为大分子递送优化的PDT之后,立即注射低剂量的Doxil ®(5 mg / kg)可治愈80%的经治疗的小鼠,而用相同剂量的任一Doxil ®或PDT可以分别治愈0%或18%。由于真正的光动力剂量是治疗期间产生的单线态氧的量,因此可以假设观察到的注量速率效应的潜在机理是在低注量速率下该活性氧种类的沉积增加。在文献中已经表明,体内光敏剂光漂白可以用作单重态氧沉积的间接量度。与研究的其他光敏剂(例如 PPIX或mTHPC)不同,已发现体内 HPPH光漂白在高通量率下比低通量率更有效。该结果表明,可能是由于I型光化学作用引起的缺氧途径是体内体内 HPPH光漂白的原因。进一步发现,HPPH体内光漂白可以描述为通量和通量率的函数。使用这种光漂白的数学描述,得出光动力学剂量的表达式,该表达式可以准确预测给定注量和注量速率下的肿瘤反应。

著录项

  • 作者

    Snyder, John William, II.;

  • 作者单位

    State University of New York at Buffalo.;

  • 授予单位 State University of New York at Buffalo.;
  • 学科 Biophysics Medical.; Health Sciences Oncology.
  • 学位 Ph.D.
  • 年度 2003
  • 页码 186 p.
  • 总页数 186
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物物理学;肿瘤学;
  • 关键词

  • 入库时间 2022-08-17 11:45:52

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号